SCHEMBL23072207

SCHEMBL23072207

CC[C@H]1c2cc(OC)ccc2OC[C@@]1(C)N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 7/20 1.00
SIGMAR1 Q99720 7/20 1.00
HTR1A P08908 7/20 1.00
SLC6A2 P23975 2/20 0.69
HTR2C P28335 2/20 0.69
TMEM97 Q5BJF2 4/20 0.63
ADRB2 P07550 1/20 0.59
ADRA2A P08913 1/20 0.59
ADRA2B P18089 1/20 0.59
HRH1 P35367 1/20 0.59
OPRM1 P35372 1/20 0.59
OPRK1 P41145 1/20 0.59
HTR5A P47898 1/20 0.59
SLC6A3 Q01959 1/20 0.59
HTR7 P34969 3/20 0.50
ENPP2 Q13822 1/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23072223 0.82 HTR2B (1.00) HTR2BSIGMAR1HTR1ASLC6A2HTR2C
SCHEMBL23072225 0.77 HTR2B (1.00) HTR2BSIGMAR1HTR1ASLC6A2HTR2C
SCHEMBL23072212 0.74 HTR2B (1.00) HTR2BSIGMAR1HTR1ASLC6A2HTR2C
SCHEMBL23072173 0.72 HTR2B (0.60) HTR2BSIGMAR1HTR1ASLC6A2HTR2C
SCHEMBL24090506 0.71 HTR2B (0.55) HTR2BSIGMAR1HTR1ATMEM97HTR7
SCHEMBL9627798 0.67 HTR1A (0.50) HTR2BSIGMAR1HTR1AHTR2CTMEM97
Methylamine SCHEMBL10700891 0.67 HTR1A (0.50) HTR2BSIGMAR1HTR1AHTR2CTMEM97
SCHEMBL23072232 0.67 HTR2B (1.00) HTR2BSIGMAR1HTR1AHTR2CTMEM97
SCHEMBL24075133 0.65 HCRTR1 (0.48) HTR2BSIGMAR1HTR1AHTR2CTMEM97
SCHEMBL24075132 0.65 HCRTR1 (0.48) HTR2BSIGMAR1HTR1AHTR2CTMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941153-B2 Substituted phenethylamine derivatives REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2021-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10941153-B2 Substituted phenethylamine derivatives PNMT, PRMT1, PRMT3 HTR2B 124/4885SIGMAR1 97/4885HTR1A 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.